<DOC>
	<DOCNO>NCT02189109</DOCNO>
	<brief_summary>This clinical trial test safety , tolerability effectiveness NVX-108 administer via intravenous infusion combination standard radiation chemotherapy . NVX-108 develop increase amount oxygen deliver tumor hop increase effectiveness radiation therapy .</brief_summary>
	<brief_title>The Effects NVX-108 Radiation Sensitizer Glioblastoma</brief_title>
	<detailed_description />
	<mesh_term>Glioblastoma</mesh_term>
	<criteria>1 . Histologicallyconfirmed newlydiagnosed glioblastoma multiforme . 2 . No prior treatment glioblastoma apart surgical resection . 3 . No prior treatment glioblastoma apart surgical resection . 4 . Planned 60 Gray focal radiation administer 30 fraction , concurrently temozolomide chemotherapy . 5 . Manageable risk associate potential radiation necrosis radiation field , base size field proximity eloquent brain region ( assessed investigator ) . 6 . Aged 1870 year . 7 . ECOG performance status 02 . 8 . Life expectancy least 3 month . 9 . If receive glucocorticoid therapy , dose must stable least 7 day prior study enrollment . 10 . Archived tumor tissue available central review . 11 . Able undergo gadoliniumenhanced MRI ( GdMRI ) scan . 12 . Baseline MRI perform within 14 day start study treatment , stable glucocorticoid dose least 5 day image study . 13 . Adequate hematologic , renal hepatic function , define : Absolute neutrophil count ( ANC ) ≥ 1.5 109/L Platelet count ≥ 100 109/L Hemoglobin ≥ 90 g/L International normalized ratio ( INR ) activate partial thromboplastin time ( APTT ) &lt; 1.5 upper limit normal ( ULN ) Plasma creatinine &lt; 1.5 ULN Total bilirubin within normal limit ( &lt; 2.5 ULN Gilbert 's syndrome ) AST ALT &lt; 2.5 ULN 14 . Patients woman childbearing potential men ( unless vasectomise ) must agree use highlyeffective method birth control , hormonal contraceptive implant , combine oral contraceptive , intrauterine device , doublebarrier method ( eg . condom diaphragm ) abstinence , study entry 4 month complete study therapy . Should woman become pregnant suspect pregnant partner participate study , inform treat physician immediately . 15 . Ability understand willingness sign write informed consent document . 1 . Presence leptomeningeal disease multifocal glioblastoma encompass within feasible safe radiation field . 2 . Intracranial bleeding , except stable grade 1 hemorrhage . 3 . Has recover adverse effect surgical resection biopsy , except neurological deficit . 4 . Patients receive investigational agent within 4 week enrollment . 5 . Stroke transient ischemic attack within 6 month enrollment . 6 . Myocardial infarction within 6 month enrollment , unstable angina , New York Heart Association class II great congestive heart failure , uncontrolled hypertension ( systolic BP &gt; 160 mmHg and/or diastolic BP &gt; 100 mmHg ) . 7 . Congenital long QT syndrome . 8 . Clinicallysignificant chronic obstructive pulmonary disease asthma . 9 . Active major infection require treatment . 10 . A history malignancy , except adequately treat nonmelanoma skin cancer , curatively treated insitu cancer solid tumor curatively treat evidence disease ≥ 2 year . 11 . Known infection human immunodeficiency virus hepatitis B C virus . 12 . Current anticoagulant antiplatelet therapy , except prophylactic dos low molecular weight heparin lowdose aspirin . 13 . History allergic reaction attribute compound similar chemical composition NVX108 . 14 . Women pregnant breast feeding . 15 . Inability comply study procedure . 16 . History evidence clinicallysignificant condition , opinion investigator , would pose risk subject safety interfere study procedure , evaluation completion .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>glioblastoma</keyword>
	<keyword>multiforme</keyword>
	<keyword>radiation</keyword>
	<keyword>radiation therapy</keyword>
</DOC>